HT
VRTX icon

HAP Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

HAP Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,600
Closed -$70.8K – 824
2024
Q2 		$70.8K Buy
+12,600
New +$5.47M 0.01% 404
2022
Q3 		– Sell
-11,500
Closed -$34K – 2100
2022
Q2 		$34K Sell
11,500
-100
-0.9% -$26.8K ﹤0.01% 1184
2022
Q1 		$86K Sell
11,600
-5,100
-31% -$1.21M ﹤0.01% 1103
2021
Q4 		$219K Buy
16,700
+4,000
+31% +$778K 0.01% 989
2021
Q3 		$331K Sell
12,700
-1,100
-8% -$215K 0.01% 830
2021
Q2 		$244K Buy
+13,800
New +$2.89M 0.01% 930
2021
Q1 		– Sell
-16,500
Closed -$211K – 2523
2020
Q4 		$211K Buy
+16,500
New +$3.79M 0.01% 941
2019
Q1 		– Sell
-11,400
Closed -$95K – 1394
2018
Q4 		$95K Buy
+11,400
New +$1.98M 0.01% 649
2018
Q2 		– Sell
-12,000
Closed -$126K – 1143
2018
Q1 		$126K Buy
+12,000
New +$1.96M 0.01% 518
2017
Q4 		– Sell
-28,600
Closed -$121K – 1184
2017
Q3 		$121K Buy
+28,600
New +$4.3M 0.01% 553
2017
Q2 		– Sell
-15,800
Closed -$23K – 1180
2017
Q1 		$23K Sell
15,800
-1,600
-9% -$141K ﹤0.01% 812
2016
Q4 		$274K Sell
17,400
-10,100
-37% -$822K 0.01% 427
2016
Q3 		$254K Buy
+27,500
New +$2.6M 0.01% 460
2015
Q3 		– Sell
-20,500
Closed -$7K – 1197
2015
Q2 		$7K Sell
20,500
-7,800
-28% -$983K ﹤0.01% 879
2015
Q1 		$174K Sell
28,300
-91,800
-76% -$11M 0.01% 462
2014
Q4 		$60K Sell
120,100
-700
-0.6% -$78.8K ﹤0.01% 702
2014
Q3 		$544K Buy
120,800
+96,100
+389% +$9.15M 0.02% 451
2014
Q2 		$4K Buy
+24,700
New +$1.73M ﹤0.01% 892

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HAP Trading's VRTX Position: Q2 2018 in Review

HAP Trading sold out of Vertex Pharmaceuticals (VRTX) in Q2 2018, closing a stake of 26,719 shares — an estimated $4.36M sold.

HAP Trading first reported a position in VRTX in Q3 2014 and held it in 5 quarters. The position peaked at $40.8M in Q3 2017. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

  • HAP Trading reported no remaining Vertex Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • HAP Trading sold 26,719 Vertex Pharmaceuticals shares in Q2 2018, an estimated $4.36M.
  • HAP Trading first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • HAP Trading's Vertex Pharmaceuticals position peaked at $40.8M in Q3 2017.
  • 690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.